Skip to main content
SpringerLink
Log in

Antimicrobial Activity of Terpens and Oxygen-Containing Terpenoids against Staphylococcus aureus

  • SHORT COMMUNICATIONS
  • Published:
Microbiology Aims and scope Submit manuscript

Abstract

Staphylococcus aureus causes many diseases under pathological conditions. Due to the rapid development of antibiotic resistance, the search for alternative approaches to antimicrobial treatment of Staphylococci is challenging. Natural and synthetic terpenoids, due to their membranotropic properties, both exhibit antimicrobial properties and potentiate other antibiotics. The antimicrobial activity of 53 natural terpenes and their synthetic oxygen-containing derivatives, as well as their ability to potentiate the effect of conventional antimicrobials against S. aureus, has been assessed. It has been shown that (+)-3β,4β-carandiol and (−)-myrtenic acid increase the efficiency of amikacin, ceftriaxone, and miramistin up to 4-fold, thus suggesting them as promising agents for combination therapy with antimicrobials to reduce active concentrations of the latter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Bhattacharya, R., Rolta, R., Dev, K., and Sourirajan, A., Synergistic potential of essential oils with antibiotics to combat fungal pathogens: Present status and future perspectives, Phytother. Res.: PTR, 2021, vol. 35, pp. 6089–6100.

    Article  CAS  PubMed  Google Scholar 

  2. Chambers, H.F. and Deleo, F.R., Waves of resistance: Staphylococcus aureus in the antibiotic era, Nature Rev. Microbiol., 2009, vol. 7, pp. 629–641.

    Article  CAS  Google Scholar 

  3. Cheesman, M.J., Ilanko, A., Blonk, B., and Cock, I.E., Developing new antimicrobial therapies: are synergistic combinations of plant extracts/compounds with conventional antibiotics the solution?, Pharmacogn. Rev., 2017, vol. 11, pp. 57–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Chouhan, S., Sharma, K., and Guleria, S., Antimicrobial activity of some essential oils—present status and future perspectives, Medicines, 2017, vol. 4, no. 3, p. 58.

    Article  PubMed  PubMed Central  Google Scholar 

  5. D’Arrigo, M., Ginestra, G., Mandalari, G., Furneri, P.M., and Bisignano, G., Synergism and postantibiotic effect of tobramycin and Melaleuca alternifolia (tea tree) oil against Staphylococcus aureus and Escherichia coli, Phytomedicine, 2010, vol. 17, no. 5, pp. 317–322.

    Article  PubMed  Google Scholar 

  6. den Hollander, J.G., Mouton, J.W., and Verbrugh, H.A., Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics, Antimicrob. Agents Chemotherap., 1998, vol. 42, no. 4, pp. 744–748.

    Article  CAS  Google Scholar 

  7. Devi, K.P., Nisha, S.A., Sakthivel, R., and Pandian, S.K., Eugenol (an essential oil of clove) acts as an antibacterial agent against Salmonella typhi by disrupting the cellular membrane, J. Ethnopharmacol., 2010, vol. 130, no. 1, pp. 107–115.

    Article  CAS  PubMed  Google Scholar 

  8. Leclercq, R., Cantón, R., Brown, D.F., Giske, C.G., Heisig, P., MacGowan, A.P., and Kahlmeter, G., EUCAST expert rules in antimicrobial susceptibility testing, Clinical Microbiol. Infection., 2013, vol. 19, no. 2, pp. 141–160.

    Article  CAS  Google Scholar 

  9. Lewis, K., Platforms for antibiotic discovery, Nat. Rev. Drug Discov., 2013, vol. 12, pp. 371–387.

    Article  CAS  PubMed  Google Scholar 

  10. Lister, J.L. and Horswill, A.R., Staphylococcus aureus biofilms: recent developments in biofilm dispersal, Front. Cell. Infect. Microbiol., 2014, vol. 4, p. 178.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Mahmoud, R.Y., Trizna, E.Y., Sulaiman, R.K., Pavelyev, R.S., Gilfanov, I.R., Lisovskaya, S.A., Ostolopovskaya, O.V., Frolova, L.L., Kutchin, A.V., Guseva, G.B., Antina, E.V., Berezin, M.B., Nikitina, L.E., and Kayumov, A.R., Increasing the efficacy of treatment of Staphylococcus aureus–Candida albicans mixed infections with myrtenol, Antibiotics, 2022, vol. 11, no. 12, p. 1743.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Miklasińska-Majdanik, M., Mechanisms of resistance to macrolide antibiotics among Staphylococcus aureus, Antibiotics, 2021, vol. 10, p. 1406.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Puvača, N. and de Llanos Frutos, R., Antimicrobial resistance in Escherichia coli strains isolated from humans and pet animals, Antibiotics, 2021, vol. 10, pp. 1–63.

    Article  Google Scholar 

  14. Shrivastava, S.R., Shrivastava, P.S., and Ramasamy, J., World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics, Med. Soc., 2018, vol. 32, pp. 7–76.

    Google Scholar 

  15. Tarmo N., Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus, Eur. J. Med. Chem., 2018, vol. 157, pp. 198–228.

    Article  Google Scholar 

  16. Zaman, S.B., Hussain, M.A., Nye, R., Mehta, V., Mamun, K.T., and Hossain, N., A review on antibiotic resistance: alarm bells are ringing, Cureus, 2017, vol. 9, p. e1403.

    PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was funded by the subsidy allocated to Kazan Federal University for the state assignment in the sphere of scientific activities, project no. FZSM-2022-0017.

Author information

Authors and Affiliations

  1. Kazan (Volga) Federal University, 420008, Kazan, Russia

    A. I. Kolesnikova, A. R. Kayumov, I. R. Gilfanov & E. Y. Trizna

  2. Kazan State Medical University, 420111, Kazan, Russia

    L. E. Nikitina

  3. Institute of Chemistry Komi Scientific Center Ural Branch Russian Academy of Sciences, 167000, Syktyvkar, Russia

    L. L. Frolova

Authors
  1. A. I. Kolesnikova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. R. Kayumov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. R. Gilfanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. L. Frolova
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. E. Nikitina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Y. Trizna
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

K.A.I., F.L.L., G.I.R.—experimental procedures, K.A.R., T.E.Y., N.L.E.—work management; all authors participated in writing and approving the manuscript.

Corresponding author

Correspondence to E. Y. Trizna.

Ethics declarations

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

This work does not contain any studies involving human and animal subjects.

CONFLICT OF INTEREST

The authors of this work declare that they have no conflicts of interest.

Additional information

Publisher’s Note.

Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kolesnikova, A.I., Kayumov, A.R., Gilfanov, I.R. et al. Antimicrobial Activity of Terpens and Oxygen-Containing Terpenoids against Staphylococcus aureus. Microbiology 93, 385–388 (2024). https://doi.org/10.1134/S002626172360427X

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S002626172360427X

Keywords:

Search

Navigation